Information Journal Paper
APA:
Copy. (2017). Clinical benefit, price, approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015. ANNALS OF ONCOLOGY (OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: ESMO), 28(5), 1111-1116. SID. https://sid.ir/paper/720981/en
Vancouver:
Copy. Clinical benefit, price, approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015. ANNALS OF ONCOLOGY (OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: ESMO)[Internet]. 2017;28(5):1111-1116. Available from: https://sid.ir/paper/720981/en
IEEE:
Copy, “Clinical benefit, price, approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015,” ANNALS OF ONCOLOGY (OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: ESMO), vol. 28, no. 5, pp. 1111–1116, 2017, [Online]. Available: https://sid.ir/paper/720981/en